This has been addressed multiple times. Biotechs c
Post# of 148300
(Total Views: 412)
Posted On: 01/17/2020 11:21:16 AM
This has been addressed multiple times. Biotechs cannot market a drug that’s not FDA approved and they have to be careful how they get the leronlimab name out there before approval.
I don’t know if biotechs can market trial enrollment, either (for example, an announcement on their Facebook page and shared with other cancer pages). But it seems that with 50-60 patients waiting to be screened, CYDY shouldn’t have a problem getting patients for the mTNBC trial or basket trial (once approved).
I don’t know if biotechs can market trial enrollment, either (for example, an announcement on their Facebook page and shared with other cancer pages). But it seems that with 50-60 patients waiting to be screened, CYDY shouldn’t have a problem getting patients for the mTNBC trial or basket trial (once approved).
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼